SA
TXG icon

Sanctuary Advisors’s 10x Genomics TXG Stock Holding History

Sanctuary Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$690K Buy
+18,002
New +$472K ﹤0.01% 1735
2025
Q2 		– Sell
-23,778
Closed -$208K – 2452
2025
Q1 		$208K Sell
23,778
-655
-3% -$8.26K ﹤0.01% 2019
2024
Q4 		$368K Buy
24,433
+6,474
+36% +$102K ﹤0.01% 1876
2024
Q3 		$257K Buy
+17,959
New +$371K ﹤0.01% 2095

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanctuary Advisors's TXG Position: Q2 2026 in Review

Sanctuary Advisors opened a new position in 10x Genomics (TXG) in Q2 2026: 18,002 shares worth $690K. The stake represents ﹤0.01% of the portfolio and ranks #1735 among its holdings. This is a return to the name: Sanctuary Advisors previously reported a position in TXG as recently as Q1 2025.

Sanctuary Advisors first reported a position in TXG in Q3 2024 and has held it in 4 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Sanctuary Advisors held 18,002 shares of 10x Genomics worth $690K as of Q2 2026.
  • 10x Genomics was a new Sanctuary Advisors position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1735 holding.
  • Sanctuary Advisors first reported a position in 10x Genomics in Q3 2024 and has held it in 4 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.